Donnelly LA, Singh K, McCrimmon RJ, Pearson ER, et al. One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population. Diabetes Obes Metab 2025 Nov 4. doi: 10.1111/dom.70269.
PMID: 41189335